QL Block + ERAS Protocol for Postoperative Pain
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial compares two methods for managing pain after surgery in women with pelvic organ prolapse. The goal is to determine if a nerve block, known as the quadratus lumborum (QL) block, reduces pain and opioid use more effectively than the standard Enhanced Recovery After Surgery (ERAS) protocol. Women undergoing robotic-assisted sacrocolpopexy surgery, who have had or will have a hysterectomy, are suitable candidates for this trial. Participants will either receive the QL block or follow the ERAS protocol to manage post-surgical pain. The study aims to identify which method reduces pain and opioid use more effectively immediately after surgery. As an unphased trial, it offers participants the chance to contribute to research that could enhance post-surgical pain management for future patients.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.
What prior data suggests that the QL block and ERAS protocol are safe for managing postoperative pain?
Research has shown that the quadratus lumborum (QL) block is generally safe and well-tolerated. One study found it significantly reduced nausea after surgery, a common anesthesia side effect. Patients who received the QL block reported less pain 12 and 24 hours post-surgery compared to those who did not receive it. This suggests it effectively manages pain without major side effects.
For the Enhanced Recovery After Surgery (ERAS) protocol, studies have shown it is safe and effective. ERAS programs reduce the need for opioids after surgery, lowering the risk of side effects from these drugs. ERAS also improves recovery by encouraging early movement and using various methods to manage pain, making it a trusted approach in surgical care.
Both the QL block and ERAS protocols have demonstrated good safety records in previous research, making them promising options for managing pain after surgery.12345Why are researchers excited about this trial?
Researchers are excited about the QL Block and ERAS Protocol because they offer innovative approaches to managing postoperative pain. The QL Block is unique because it targets the quadratus lumborum muscle to deliver pain relief directly to the abdominal region, potentially reducing the need for opioids. This method uses ropivacaine, a local anesthetic, to provide targeted pain control. Meanwhile, the ERAS Protocol is a comprehensive strategy that focuses on minimizing opioid use by combining various pain management techniques, like early ambulation and the use of acetaminophen and NSAIDs. Both approaches aim to enhance recovery times and reduce reliance on opioids, addressing common concerns with traditional pain management.
What evidence suggests that this trial's treatments could be effective for managing postoperative pain?
In this trial, participants will join one of two treatment arms to manage postoperative pain. Research has shown that the quadratus lumborum (QL) block, which participants in one arm may receive, effectively reduces pain after surgery. Studies have found that it lowers pain levels and reduces the need for opioid painkillers during recovery. Specifically, patients who received the QL block after certain surgeries reported less pain and used fewer painkillers compared to those who did not receive the block.
Participants in the other arm will follow the Enhanced Recovery After Surgery (ERAS) protocol, known to improve pain management and reduce opioid use. This protocol combines different pain relief methods to help patients recover faster and with fewer complications. Evidence indicates that ERAS can lead to lower pain levels and a decrease in the need for opioids after surgery.
Both approaches in this trial aim to manage pain more effectively and reduce reliance on opioids, which can have negative side effects.23678Are You a Good Fit for This Trial?
This trial is for English-speaking women aged 18 or older who are undergoing robotic-assisted surgery for pelvic organ prolapse, with or without concurrent hysterectomy. Participants must be able to consent.Inclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Preoperative Preparation
Participants receive either the QL block or follow the ERAS protocol prior to surgery
Immediate Postoperative
Participants are monitored in the PACU for pain scores, opioid requirements, and other postoperative outcomes
Follow-up
Participants are monitored for safety and effectiveness after treatment
What Are the Treatments Tested in This Trial?
Interventions
- Enhanced Recovery After Surgical (ERAS) Protocol
- Quadratus Lumborum (QL) Block
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Alabama at Birmingham
Lead Sponsor